Company Description
Hoffmann-La Roche is the US prescription pharmaceuticals unit of Roche. The company develops, manufactures, and markets drugs to treat such...
Key Hoffmann-La Roche Financials
| Company Type | Subsidiary of Roche - Main Headquarters |
|---|---|
| Fiscal Year-End | December |
| 2005 Employees | 5,000 |
More Hoffmann-La Roche Financials (1 pages)
Competition
Competitive Landscape for Biotechnology Sector
The industry is marked by rapid advances in scientific knowledge that produce ever-more effective medicines. Profitability is determined mainly by the ability to discover new drugs. The industry is...
Read more about Hoffmann-La Roche's competition across multiple industries
Top Hoffmann-La Roche Competitors
Sponsored Links
The Business DirectoryHoffmann-La Roche Executives
| Title | Name & Bio | Contact |
|---|---|---|
| President and CEO | George B. Abercrombie | Network | E-mail |
| VP Finance and Information Technology | Ivor MacLeod | Network | E-mail |
| VP, Public Affairs | Carolyn R. Glynn | Network | E-mail |
More Hoffmann-La Roche Executives
| Are You Listed On Hoover's? | ||
|---|---|---|
| Hoover's subscribers also get access to information on people who have self-listed with this company. Subscribers also have the option to add themselves to this company record. |
Current Hoffmann-La Roche News
- BioWorld Today August 29, 2008 [BioWorld Today] (29 Aug 2008 00:01:00 EDT)
- Pyridine-2-carboxyamide derivatives [U.S. Patents] (25 Aug 2008 12:25:00 EDT)
- 4-oxo-2,3,4,5-tetrahydro-benzo[b][1,4]diazepine derivatives [U.S. Patents] (25 Aug 2008 12:25:00 EDT)
Sponsored Opportunity










